CY1109795T1 - Νεες τρικυκλικες διϋδροπυραζινες ως παραγοντες ανοiγματος του καναλιου καλιου - Google Patents

Νεες τρικυκλικες διϋδροπυραζινες ως παραγοντες ανοiγματος του καναλιου καλιου

Info

Publication number
CY1109795T1
CY1109795T1 CY20101100122T CY101100122T CY1109795T1 CY 1109795 T1 CY1109795 T1 CY 1109795T1 CY 20101100122 T CY20101100122 T CY 20101100122T CY 101100122 T CY101100122 T CY 101100122T CY 1109795 T1 CY1109795 T1 CY 1109795T1
Authority
CY
Cyprus
Prior art keywords
dyropyrazines
channel opening
potential channel
new tricyclic
opening factors
Prior art date
Application number
CY20101100122T
Other languages
English (en)
Inventor
Zhihua Sui
Xuqing Zhang
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1109795T1 publication Critical patent/CY1109795T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Luminescent Compositions (AREA)
  • Glass Compositions (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε νέα παράγωγα τρικυκλικής διυδροπυραζίνης, σε φαρμακευτικές συνθέσεις που τα περιέχουν και στη χρήση τους στη θεραπεία διαταραχών που σχετίζονται με το κανάλι καλίου.
CY20101100122T 2006-02-10 2010-02-09 Νεες τρικυκλικες διϋδροπυραζινες ως παραγοντες ανοiγματος του καναλιου καλιου CY1109795T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77250806P 2006-02-10 2006-02-10
EP07756563A EP1994012B1 (en) 2006-02-10 2007-02-01 Novel tricyclic dihydropyrazines as potassium channel openers

Publications (1)

Publication Number Publication Date
CY1109795T1 true CY1109795T1 (el) 2014-09-10

Family

ID=38179606

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100122T CY1109795T1 (el) 2006-02-10 2010-02-09 Νεες τρικυκλικες διϋδροπυραζινες ως παραγοντες ανοiγματος του καναλιου καλιου

Country Status (15)

Country Link
US (1) US7674793B2 (el)
EP (1) EP1994012B1 (el)
JP (1) JP2009526079A (el)
CN (1) CN101415690A (el)
AT (1) ATE451359T1 (el)
AU (1) AU2007215005A1 (el)
CA (1) CA2642212A1 (el)
CY (1) CY1109795T1 (el)
DE (1) DE602007003697D1 (el)
DK (1) DK1994012T3 (el)
ES (1) ES2336384T3 (el)
PL (1) PL1994012T3 (el)
PT (1) PT1994012E (el)
SI (1) SI1994012T1 (el)
WO (1) WO2007095424A1 (el)

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US306316A (en) * 1884-10-07 Joseph
US1550048A (en) * 1922-06-17 1925-08-18 Ruben Samuel Apparatus for recording electrical signals
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
EP0539154B1 (en) 1991-10-21 1997-12-29 Zeneca Limited Acridine-1,8-dione-derivatives as therapeutic agents
US20020044689A1 (en) * 1992-10-02 2002-04-18 Alex Roustaei Apparatus and method for global and local feature extraction from digital images
US5454046A (en) * 1993-09-17 1995-09-26 Penkey Corporation Universal symbolic handwriting recognition system
US5634730A (en) * 1995-11-06 1997-06-03 Bobry; Howard H. Hand-held electronic printer
US6686910B2 (en) * 1996-04-22 2004-02-03 O'donnell, Jr. Francis E. Combined writing instrument and digital documentor apparatus and method of use
US6122042A (en) * 1997-02-07 2000-09-19 Wunderman; Irwin Devices and methods for optically identifying characteristics of material objects
US5880451A (en) * 1997-04-24 1999-03-09 United Parcel Service Of America, Inc. System and method for OCR assisted bar code decoding
US6128414A (en) * 1997-09-29 2000-10-03 Intermec Ip Corporation Non-linear image processing and automatic discriminating method and apparatus for images such as images of machine-readable symbols
US6775361B1 (en) * 1998-05-01 2004-08-10 Canon Kabushiki Kaisha Recording/playback apparatus with telephone and its control method, video camera with telephone and its control method, image communication apparatus, and storage medium
US6518279B2 (en) * 1999-03-04 2003-02-11 Abbott Laboratories Cyclopentanone dihydropyridine compounds useful as potassium channel openers
US6486874B1 (en) * 2000-11-06 2002-11-26 Motorola, Inc. Method of pre-caching user interaction elements using input device position
US6550685B1 (en) * 2000-11-14 2003-04-22 Hewlett-Packard Development Company Lp Methods and apparatus utilizing visually distinctive barcodes
JP2003058841A (ja) * 2001-08-09 2003-02-28 Satoshi Mizoguchi 二次元コード
US7239747B2 (en) * 2002-01-24 2007-07-03 Chatterbox Systems, Inc. Method and system for locating position in printed texts and delivering multimedia information
US20040225282A1 (en) * 2003-05-09 2004-11-11 Ness Anton P. Method and articles for assuring appropriate surgery
JP2006527774A (ja) * 2003-06-16 2006-12-07 アラーガン、インコーポレイテッド メマンチン経口製剤
CA2529040A1 (en) * 2003-08-15 2005-02-24 Silverbrook Research Pty Ltd Improving accuracy in searching digital ink
US6921223B2 (en) * 2003-09-15 2005-07-26 Sanford, L.P. Combo pen
US7298904B2 (en) * 2004-01-14 2007-11-20 International Business Machines Corporation Method and apparatus for scaling handwritten character input for handwriting recognition
US7659915B2 (en) * 2004-04-02 2010-02-09 K-Nfb Reading Technology, Inc. Portable reading device with mode processing
US7439954B2 (en) * 2004-04-15 2008-10-21 Logitech Europe S.A. Multi-light-source illumination system for optical pointing devices
US7372993B2 (en) * 2004-07-21 2008-05-13 Hewlett-Packard Development Company, L.P. Gesture recognition
JP2006127025A (ja) * 2004-10-27 2006-05-18 Design Barcode Kk デザインバーコード
US20060155589A1 (en) * 2005-01-10 2006-07-13 Welch Allyn, Inc. Portable vital signs measurement instrument and method of use thereof

Also Published As

Publication number Publication date
ES2336384T3 (es) 2010-04-12
US7674793B2 (en) 2010-03-09
EP1994012B1 (en) 2009-12-09
ATE451359T1 (de) 2009-12-15
CA2642212A1 (en) 2007-08-23
DE602007003697D1 (de) 2010-01-21
PT1994012E (pt) 2010-01-18
PL1994012T3 (pl) 2010-05-31
CN101415690A (zh) 2009-04-22
EP1994012A1 (en) 2008-11-26
JP2009526079A (ja) 2009-07-16
AU2007215005A1 (en) 2007-08-23
WO2007095424A1 (en) 2007-08-23
SI1994012T1 (sl) 2010-03-31
US20070191382A1 (en) 2007-08-16
DK1994012T3 (da) 2010-04-06

Similar Documents

Publication Publication Date Title
PL1937669T3 (pl) Nowe pochodne benzopiranu jako „otwieracze" kanału potasowego
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
MY153258A (en) Pyrazinone derivatives and their use inthe threatment of lung diseases
SG10201805844QA (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
GEP20146125B (en) Aminopyrimidines as syk inhibitors
EA201100503A1 (ru) Глюкозидные производные и их применения
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
MX2011006006A (es) Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
HRP20070076A2 (en) Pyrimidine derivatives
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
EA201200918A1 (ru) Производные пирролидин карбоновой кислоты как агонисты сопряженного с g-белком рецептора 43 (gpr43), фармацевтическая композиция и методы их использования при лечении метаболических нарушений
MEP1008A (xx) 3-aminociklopentankarboksamidi kao modulatori receptora hemokina
SG158091A1 (en) Imidazoazepinone compounds
WO2008028935A3 (en) Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents
EA201100502A1 (ru) Гликозидные производные и их применения
ATE474574T1 (de) Imidazoazephinonverbindungen
ATE473741T1 (de) Neue imidazolopyrazolderivate als selektive androgen-rezeptor-modulatoren
GB0407025D0 (en) Novel compounds
CY1109795T1 (el) Νεες τρικυκλικες διϋδροπυραζινες ως παραγοντες ανοiγματος του καναλιου καλιου
CY1114515T1 (el) Νεα παραγωγα βενζοπυρανιου ως διανοικτες διαυλου καλιου
UA105010C2 (uk) 1,2,5-оксадіазоли як інгібітори індоламін-2,3-діоксигенази